Free Trial
OTCMKTS:PXSLY

Pharmaxis (PXSLY) Stock Price, News & Analysis

Pharmaxis logo
$0.88 0.00 (0.00%)
As of 06/8/2021

About Pharmaxis Stock (OTCMKTS:PXSLY)

Key Stats

Today's Range
$0.88
$0.88
50-Day Range
$0.88
$0.88
52-Week Range
$0.62
$1.47
Volume
N/A
Average Volume
1,000 shs
Market Capitalization
$26.53 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Pharmaxis Ltd engages in the research, development, and commercialization of healthcare products for the treatment of fibrotic and inflammatory diseases worldwide. The company operates through two segments, Mannitol business, and New Drug Development. It offers Bronchitol, an inhaled dry powder for the treatment of cystic fibrosis; and Aridol, an airways inflammation test that is used to identify twitchy or hyper-responsive airways, as well as to assist in diagnosing and managing asthma. The company's product pipeline consists of amine oxidase inhibitors comprising semicarbazide-sensitive amine oxidase for diabetic retinopathy; selective lysyl oxidase like inhibitors targeting chronic fibrotic diseases, such as NASH, pulmonary fibrosis, kidney fibrosis, and cardiac fibrosis; and pan-lysyl oxidase inhibitors targeting severe fibrotic indications, which includes cancers and scarring. It is also developing Orbital, a dry powder inhaler to deliver high drug doses to lungs. Pharmaxis Ltd was founded in 1998 and is headquartered in Frenchs Forest, Australia.

Receive PXSLY Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Pharmaxis and its competitors with MarketBeat's FREE daily newsletter.

PXSLY Stock News Headlines

Pharmaxis Ltd March Quarter Shareholder Update
Trump Knows Exactly What He's Doing
REVEALED: $194 Trillion Trump Market Pattern Trump fires off a tweet and stocks tank… He gives a speech and the markets soar… Now, a new Trump executive order is set to set off a wave worth a potential $194 trillion in the markets. And Wall Street insider Larry Benedict says it could hand investors who missed out on Trump’s first term a second chance.
See More Headlines

PXSLY Stock Analysis - Frequently Asked Questions

Pharmaxis' stock was trading at $0.88 at the beginning of 2025. Since then, PXSLY shares have increased by 0.0% and is now trading at $0.88.
View the best growth stocks for 2025 here
.

Shares of PXSLY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Sector
Medical
Industry
Pharmaceutical Preparations
Sub-Industry
N/A
Current Symbol
OTCMKTS:PXSLY
Fax
N/A
Employees
69
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$8.75 million
Price / Cash Flow
N/A
Book Value
$0.04 per share
Price / Book
22.00

Miscellaneous

Free Float
N/A
Market Cap
$26.53 million
Optionable
Not Optionable
Beta
1.22

Social Links

20 Stocks to Sell Now Cover

Today, we are inviting you to take a free peek at our proprietary, exclusive, and up-to-the-minute list of 20 stocks that Wall Street's top analysts hate.

Many of these appear to have good fundamentals and might seem like okay investments, but something is wrong. Analysts smell something seriously rotten about these companies. These are true "Strong Sell" stocks.

Get This Free Report

This page (OTCMKTS:PXSLY) was last updated on 6/1/2025 by MarketBeat.com Staff
From Our Partners